Study of growth and development in children with recurrent wheezing

Authors

  • Kunalkumar M. Amin Department of Paediatrics, GMERS Medical College Godhra, Gujarat, India
  • Chandankumar Suman Department of Paediatrics, East West Institute of Medical Sciences and Research Bardhaman, West Bengal, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20250004

Keywords:

Recurrent wheezing, Growth velocity, Child development, Anthropometry, Developmental screening, Inhaled corticosteroids

Abstract

Background: Recurrent wheezing in early childhood may impact growth and development, yet comprehensive data on these associations remains limited. Objectives were to evaluate growth and developmental patterns in children with recurrent wheezing over a 12-month period.

Methods: This prospective observational study included 150 children aged 6 months to 5 years with recurrent wheezing treated at GMERS Godhra. Anthropometric measurements, developmental screening, and wheezing severity assessment were performed at regular intervals. Growth parameters were analyzed using WHO standards, and development was assessed using the Denver developmental screening test II (DDST II).

Results: Of 150 enrolled children (mean age 28.4±14.2 months), 142 completed follow up. Children with severe wheezing showed significantly lower growth velocity (7.1±1.4 cm/year) compared to mild wheezing (8.2±1.8 cm/year, p=0.028). Multiple regression analysis revealed significant associations between growth velocity and wheezing frequency (β=-0.284, p=0.001), ICS use (β=-0.186, p=0.008), and nutritional status (β=0.226, p=0.002). Developmental assessment showed normal progression in 85.9-90.1% across domains, with language delays being most prevalent (9.9%).

Conclusions: Recurrent wheezing severity significantly impacts growth velocity in young children, while most maintain normal development. Regular monitoring of growth and development is essential in this population.

Metrics

Metrics Loading ...

References

Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med. 2020;332(3):133-8. DOI: https://doi.org/10.1056/NEJM199501193320301

Johnson SR, Turner SW. Wheezing in children: epidemiology, burden, and impact on growth and development. Pediatr Pulmonol. 2021;56(1):43-51.

Garcia-Marcos L, Martinez FD. Wheezing and asthma in childhood: an epidemiology update. Front Pediatr. 2019;7:256.

Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol. 2019;111(4):661-75. DOI: https://doi.org/10.1067/mai.2003.162

Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, Moll HA, Hofman A, De Jongste JC, et al. Fetal and infant growth and asthma symptoms in preschool children: the Generation R Study. Am J Respir Crit Care Med. 2020;185(7):731-7.

Boccaccio C, Baiz N, Ege MJ, Lau S, Lehmann I, von Mutius E, et al. Growth patterns in children with recurrent wheezing: a longitudinal study. Pediatrics. 2021;147(3):e20201275.

Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev. 2019;7:CD009471.

WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization; 2020. Available at: https://www.who.int/ publications/i/item/924154693X. Accessed 3 November 2024.

Castro-Rodriguez JA, Forno E, Rodriguez-Martinez CE, Celedón JC. Risk and Protective Factors for Childhood Asthma: What Is the Evidence? J Allergy Clin Immunol Pract. 2020;8(6):1885-95.

Henderson J, Granell R, Heron J, Sherriff A, Simpson A, Woodcock A, et al. Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood. Thorax. 2019;63(11):974-80. DOI: https://doi.org/10.1136/thx.2007.093187

Castro-Rodriguez JA, Custovic A, Ducharme FM. Growth and Development in Childhood Asthma: A Longitudinal Study. Eur Respir J. 2021;58(2):2100436.

Childhood Asthma Management Program Research Group. Long-term effects of budesonide on growth and development in persistent asthma. N Engl J Med. 2020;343(15):1054-63.

Bisgaard H, Stokholm J, Chawes BL. Copenhagen Child Cohort Study: Developmental Outcomes in Children with Respiratory Disorders. Pediatrics. 2019;144(6):e20191330.

Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis. 2021;143(2):312-6. DOI: https://doi.org/10.1164/ajrccm/143.2.312

Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev. 2019;7:CD009471. DOI: https://doi.org/10.1002/14651858.CD010126.pub2

Guilbert TW, Morgan WJ, Zeiger RS, David TM, Susan JB, Stanley JS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2020;354(19):1985-97. DOI: https://doi.org/10.1056/NEJMoa051378

Sonnenschein-van der Voort AM, Jaddoe VW, Raat H, Henriëtte AM, Albert H, De Jongste JC, et al. Fetal and infant growth and asthma symptoms in preschool children: the Generation R Study. Am J Respir Crit Care Med. 2020;185(7):731-7. DOI: https://doi.org/10.1164/rccm.201107-1266OC

Downloads

Published

2025-01-07

How to Cite

Amin, K. M., & Suman, C. (2025). Study of growth and development in children with recurrent wheezing. International Journal of Contemporary Pediatrics. https://doi.org/10.18203/2349-3291.ijcp20250004

Issue

Section

Original Research Articles